News|Articles|July 22, 2024
Enhancing Clinical Trial Flexibility
Author(s)Catalyst
As drug development costs continue to escalate, sponsors are incentivized to find less expensive approaches to develop their assets. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service CRO offerings.
Trending on Applied Clinical Trials Online
1
What It Actually Means to Embed the Patient Voice in Trial Design
2
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
3
ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization
4
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
5